Teri O'neal, MD | |
4864 Jackson St, Department Of Emergency Medical Services, Monroe, LA 71202-6400 | |
(318) 330-7626 | |
(318) 330-7648 |
Full Name | Teri O'neal |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 41 Years |
Location | 4864 Jackson St, Monroe, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124039045 | NPI | - | NPPES |
1352942 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 017122 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Stat Home Health North, Llc | Monroe, LA | Home health agency |
Ochsner Lsu Health Monroe | Monroe, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lsu Health Sciences Center Shreveport Faculty Group Practice | 4082902721 | 529 |
News Archive
Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".
HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.
Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announces it has signed an agreement to acquire BioSeek Inc.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.
› Verified 3 days ago
Entity Name | Brfhh Monroe Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811324882 PECOS PAC ID: 0042446577 Enrollment ID: O20140403001947 |
News Archive
Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".
HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.
Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announces it has signed an agreement to acquire BioSeek Inc.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.
› Verified 3 days ago
Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".
HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.
Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announces it has signed an agreement to acquire BioSeek Inc.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Teri O'neal, MD 4864 Jackson St, Monroe, LA 71202-6400 Ph: (318) 330-7626 | Teri O'neal, MD 4864 Jackson St, Department Of Emergency Medical Services, Monroe, LA 71202-6400 Ph: (318) 330-7626 |
News Archive
Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".
HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.
Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announces it has signed an agreement to acquire BioSeek Inc.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.
› Verified 3 days ago
Jeffery Fuller, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4864 Jackson St, Department Of Emergency Medical Services, Monroe, LA 71202 Phone: 318-675-7737 Fax: 318-675-5666 | |
Dr. Roberto Eduardo Medina, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 806-831-8734 Fax: 940-205-5028 | |
Aaron Scott Klepper, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4864 Jackson St, Monroe, LA 71202 Phone: 318-330-7626 Fax: 318-330-7648 | |
Dr. Robert Mark Kerry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3421 Medical Park Dr, St Francis North Hospital, Monroe, LA 71211 Phone: 318-388-7874 Fax: 318-361-4629 | |
Daniel W Twitchell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2408 Broadmoor Blvd, Suite B, Monroe, LA 71201 Phone: 318-807-0525 Fax: 318-807-1077 | |
Michael C Rommen, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4000 |